Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus saline for NOL-index guided remifentanil analgesia during general anesthesia
2018-004512-22Phase 4Completed
- Sponsor
- Erasmus Hospital
- Start
- Jan 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and remifentanil (2 arms), sponsored by Erasmus Hospital. Primary endpoint: Intraoperative remifentanil consumption. Started Jan 2019; status: completed.
02
Drugs
dexmedetomidineremifentanil
Beyond the preview
Go deeper on 2018-004512-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004512-22.